Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1

go back to reference Schwarz GA, Liu CN (1956) Hereditary (familial) spastic paraplegia: further clinical and pathologic observations. AMA Arch Neurol Psychiatry 75:144–162PubMed Schwarz GA, Liu CN (1956) Hereditary (familial) spastic paraplegia: further clinical and pathologic observations. AMA Arch Neurol Psychiatry 75:144–162PubMed

go back to reference Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1:1151–1155. doi:10.1016/S0140-6736(83)92879-9 PubMedCrossRef Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1:1151–1155. doi:10.​1016/​S0140-6736(83)92879-9 PubMedCrossRef

go back to reference Crosby AH, Proukakis C (2002) Is the transportation highway the right road for hereditary spastic paraplegia? Am J Hum Genet 71:1009–1016. doi:10.1086/344206 PubMedCrossRef Crosby AH, Proukakis C (2002) Is the transportation highway the right road for hereditary spastic paraplegia? Am J Hum Genet 71:1009–1016. doi:10.​1086/​344206 PubMedCrossRef

go back to reference Reid E (2003) Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J Med Genet 40:81–86. doi:10.1136/jmg.40.2.81 PubMedCrossRef Reid E (2003) Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J Med Genet 40:81–86. doi:10.​1136/​jmg.​40.​2.​81 PubMedCrossRef

go back to reference Fink JK (2006) Hereditary spastic paraplegia. Curr Neurol Neurosci Rep 6:65–76. doi:10.1007/s11910-996-0011-1 PubMedCrossRef Fink JK (2006) Hereditary spastic paraplegia. Curr Neurol Neurosci Rep 6:65–76. doi:10.​1007/​s11910-996-0011-1 PubMedCrossRef

go back to reference Soderblom C, Blackstone C (2006) Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. Pharmacol Ther 109:42–56. doi:10.1016/j.pharmthera.2005.06.001 PubMedCrossRef Soderblom C, Blackstone C (2006) Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. Pharmacol Ther 109:42–56. doi:10.​1016/​j.​pharmthera.​2005.​06.​001 PubMedCrossRef

go back to reference Züchner S (2007) The genetics of hereditary spastic paraplegia and implications for drug therapy. Expert Opin Pharmacother 8:1433–1439. doi:10.1517/14656566.8.10.1433 PubMedCrossRef Züchner S (2007) The genetics of hereditary spastic paraplegia and implications for drug therapy. Expert Opin Pharmacother 8:1433–1439. doi:10.​1517/​14656566.​8.​10.​1433 PubMedCrossRef

go back to reference Stevanin G, Ruberg M, Brice A (2008) Recent advances in the genetics of spastic paraplegias. Curr Neurol Neurosci Rep 8:198–210. doi:10.1007/s11910-008-0032-z PubMedCrossRef Stevanin G, Ruberg M, Brice A (2008) Recent advances in the genetics of spastic paraplegias. Curr Neurol Neurosci Rep 8:198–210. doi:10.​1007/​s11910-008-0032-z PubMedCrossRef

go back to reference Simpson MA, Cross H, Proukakis C, Pryde A, Hershberger R, Chatonnet A, Patton MA, Crosby AH (2003) Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 73:1147–1156. doi:10.1086/379522 PubMedCrossRef Simpson MA, Cross H, Proukakis C, Pryde A, Hershberger R, Chatonnet A, Patton MA, Crosby AH (2003) Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 73:1147–1156. doi:10.​1086/​379522 PubMedCrossRef

go back to reference Zeitlmann L, Sirim P, Kremmer E, Kolanus W (2001) Cloning of ACP33 as a novel intracellular ligand of CD4. J Biol Chem 276:9123–9132. doi:10.1074/jbc.M009270200 PubMedCrossRef Zeitlmann L, Sirim P, Kremmer E, Kolanus W (2001) Cloning of ACP33 as a novel intracellular ligand of CD4. J Biol Chem 276:9123–9132. doi:10.​1074/​jbc.​M009270200 PubMedCrossRef

go back to reference Zhu P-P, Patterson A, Lavoie B, Stadler J, Shoeb M, Patel R, Blackstone C (2003) Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J Biol Chem 278:49063–49071. doi:10.1074/jbc.M306702200 PubMedCrossRef Zhu P-P, Patterson A, Lavoie B, Stadler J, Shoeb M, Patel R, Blackstone C (2003) Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J Biol Chem 278:49063–49071. doi:10.​1074/​jbc.​M306702200 PubMedCrossRef

go back to reference Zhu P-P, Patterson A, Stadler J, Seeburg DP, Sheng M, Blackstone C (2004) Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase Drp1. J Biol Chem 279:35967–35974. doi:10.1074/jbc.M404105200 PubMedCrossRef Zhu P-P, Patterson A, Stadler J, Seeburg DP, Sheng M, Blackstone C (2004) Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase Drp1. J Biol Chem 279:35967–35974. doi:10.​1074/​jbc.​M404105200 PubMedCrossRef

go back to reference Blackstone C, Roberts RG, Seeburg DP, Sheng M (2003) Interaction of the deafness–dystonia protein DDP/TIMM8a with the signal transduction adaptor molecule STAM1. Biochem Biophys Res Commun 305:345–352. doi:10.1016/S0006-291X(03)00767-8 PubMedCrossRef Blackstone C, Roberts RG, Seeburg DP, Sheng M (2003) Interaction of the deafness–dystonia protein DDP/TIMM8a with the signal transduction adaptor molecule STAM1. Biochem Biophys Res Commun 305:345–352. doi:10.​1016/​S0006-291X(03)00767-8 PubMedCrossRef

go back to reference Zheng YL, Li BS, Veeranna, Pant HC (2003) Phosphorylation of the head domain of neurofilament protein (NF-M): a factor regulating topographic phosphorylation of NF-M tail domain KSP sites in neurons. J Biol Chem 278:24026–24032. doi:10.1074/jbc.M303079200 PubMedCrossRef Zheng YL, Li BS, Veeranna, Pant HC (2003) Phosphorylation of the head domain of neurofilament protein (NF-M): a factor regulating topographic phosphorylation of NF-M tail domain KSP sites in neurons. J Biol Chem 278:24026–24032. doi:10.​1074/​jbc.​M303079200 PubMedCrossRef

go back to reference Schrag JD, Li YG, Wu S, Cygler M (1991) Ser-His-Glu triad forms the catalytic site of the lipase from Geotrichum candidum. Nature 351:761–764. doi:10.1038/351761a0 PubMedCrossRef Schrag JD, Li YG, Wu S, Cygler M (1991) Ser-His-Glu triad forms the catalytic site of the lipase from Geotrichum candidum. Nature 351:761–764. doi:10.​1038/​351761a0 PubMedCrossRef

go back to reference Holmquist M (2000) Alpha beta-hydrolase fold enzymes: structures, functions and mechanisms. Curr Protein Pept Sci 1:209–235. doi:10.2174/1389203003381405 PubMedCrossRef Holmquist M (2000) Alpha beta-hydrolase fold enzymes: structures, functions and mechanisms. Curr Protein Pept Sci 1:209–235. doi:10.​2174/​1389203003381405​ PubMedCrossRef

go back to reference Elmi F, Lee HT, Huang JY, Hsieh YC, Wang YL, Chen YJ, Shaw SY, Chen CJ (2005) Stereoselective esterase from Pseudomonas putida IFO12996 reveals alpha/beta hydrolase folds for d-beta-acetylthioisobutyric acid synthesis. J Bacteriol 187:8470–8476. doi:10.1128/JB.187.24.8470-8476.2005 PubMedCrossRef Elmi F, Lee HT, Huang JY, Hsieh YC, Wang YL, Chen YJ, Shaw SY, Chen CJ (2005) Stereoselective esterase from Pseudomonas putida IFO12996 reveals alpha/beta hydrolase folds for d-beta-acetylthioisobutyric acid synthesis. J Bacteriol 187:8470–8476. doi:10.​1128/​JB.​187.​24.​8470-8476.​2005 PubMedCrossRef

go back to reference Hecht HJ, Sobek H, Haag T, Pfeifer O, van Pee KH (1994) The metal-ion-free oxidoreductase from Streptomyces aureofaciens has an alpha/beta hydrolase fold. Nat Struct Biol 1:532–537. doi:10.1038/nsb0894-532 PubMedCrossRef Hecht HJ, Sobek H, Haag T, Pfeifer O, van Pee KH (1994) The metal-ion-free oxidoreductase from Streptomyces aureofaciens has an alpha/beta hydrolase fold. Nat Struct Biol 1:532–537. doi:10.​1038/​nsb0894-532 PubMedCrossRef

go back to reference Chen CC, Han Y, Niu W, Kulakova AN, Howard A, Quinn JP, Dunaway-Mariano D, Herzberg O (2006) Structure and kinetics of phosphonopyruvate hydrolase from Variovorax sp. Pal2: new insight into the divergence of catalysis within the PEP mutase/isocitrate lyase superfamily. Biochemistry 45:11491–11504. doi:10.1021/bi061208l PubMedCrossRef Chen CC, Han Y, Niu W, Kulakova AN, Howard A, Quinn JP, Dunaway-Mariano D, Herzberg O (2006) Structure and kinetics of phosphonopyruvate hydrolase from Variovorax sp. Pal2: new insight into the divergence of catalysis within the PEP mutase/isocitrate lyase superfamily. Biochemistry 45:11491–11504. doi:10.​1021/​bi061208l PubMedCrossRef

go back to reference Marchitti SA, Brocker C, Stagos D, Vasiliou (2008) Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 4:697–720. doi:10.1517/17425255.4.6.697 PubMedCrossRef Marchitti SA, Brocker C, Stagos D, Vasiliou (2008) Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 4:697–720. doi:10.​1517/​17425255.​4.​6.​697 PubMedCrossRef

go back to reference Jacobs FMJ, Smits SM, Noorlander CW, von Oerthel L, van der Linden AJ, Burbach JP, Smidt MP (2007) Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development 134:2673–2684. doi:10.1242/dev.02865 PubMedCrossRef Jacobs FMJ, Smits SM, Noorlander CW, von Oerthel L, van der Linden AJ, Burbach JP, Smidt MP (2007) Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development 134:2673–2684. doi:10.​1242/​dev.​02865 PubMedCrossRef

go back to reference Lassen N, Bateman JB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, Vasiliou V (2007) Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(−/−)/Aldh1a1(−/−) knock-out mice. J Biol Chem 282:25668–25676. doi:10.1074/jbc.M702076200 PubMedCrossRef Lassen N, Bateman JB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, Vasiliou V (2007) Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(−/−)/Aldh1a1(−/−) knock-out mice. J Biol Chem 282:25668–25676. doi:10.​1074/​jbc.​M702076200 PubMedCrossRef

go back to reference Vasiliou V, Nebert DW (2005) Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2:138–143PubMed Vasiliou V, Nebert DW (2005) Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2:138–143PubMed

go back to reference Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chin MC, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR, Desaki AL, Desta T, Diep E, Dolbeare TA, Donelan MJ, Dong HW, Dougherty JG, Duncan BJ, Ebbert AJ, Eichele G, Estin LK, Faber C, Facer BA, Fields R, Fischer SR, Fliss TP, Frensley C, Gates SN, Glattfelder KJ, Halverson KR, Hart MR, Hohmann JG, Howell MP, Jeung DP, Johnson RA, Karr PT, Kawal R, Kidney JM, Knapik RH, Kuan CL, Lake JH, Laramee AR, Larsen KD, Lau C, Lemon TA, Liang AJ, Liu Y, Luong LT, Michaels J, Morgan JJ, Morgan RJ, Mortrud MT, Mosqueda NF, Ng LL, Ng R, Orta GJ, Overly CC, Pak TH, Parry SE, Pathak SD, Pearson OC, Puchalski RB, Riley ZL, Rockett HR, Rowland SA, Royall JJ, Ruiz MJ, Sarno NR, Schaffnit K, Shapovalova NV, Sivisay T, Slaughterbeck CR, Smith SC, Smith KA, Smith BI, Sodt AJ, Stewart NN, Stumpf KR, Sunkin SM, Sutram M, Tam A, Teemer CD, Thaller C, Thompson CL, Varnam LR, Visel A, Whitlock RM, Wohnoutka PE, Wolkey CK, Wong VY, Wood M, Yaylaoglu MB, Young RC, Youngstrom BL, Yuan XF, Zhang B, Zwingman TA, Jones AR (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168–176. doi:10.1038/nature05453 PubMedCrossRef Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chin MC, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR, Desaki AL, Desta T, Diep E, Dolbeare TA, Donelan MJ, Dong HW, Dougherty JG, Duncan BJ, Ebbert AJ, Eichele G, Estin LK, Faber C, Facer BA, Fields R, Fischer SR, Fliss TP, Frensley C, Gates SN, Glattfelder KJ, Halverson KR, Hart MR, Hohmann JG, Howell MP, Jeung DP, Johnson RA, Karr PT, Kawal R, Kidney JM, Knapik RH, Kuan CL, Lake JH, Laramee AR, Larsen KD, Lau C, Lemon TA, Liang AJ, Liu Y, Luong LT, Michaels J, Morgan JJ, Morgan RJ, Mortrud MT, Mosqueda NF, Ng LL, Ng R, Orta GJ, Overly CC, Pak TH, Parry SE, Pathak SD, Pearson OC, Puchalski RB, Riley ZL, Rockett HR, Rowland SA, Royall JJ, Ruiz MJ, Sarno NR, Schaffnit K, Shapovalova NV, Sivisay T, Slaughterbeck CR, Smith SC, Smith KA, Smith BI, Sodt AJ, Stewart NN, Stumpf KR, Sunkin SM, Sutram M, Tam A, Teemer CD, Thaller C, Thompson CL, Varnam LR, Visel A, Whitlock RM, Wohnoutka PE, Wolkey CK, Wong VY, Wood M, Yaylaoglu MB, Young RC, Youngstrom BL, Yuan XF, Zhang B, Zwingman TA, Jones AR (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168–176. doi:10.​1038/​nature05453 PubMedCrossRef

go back to reference Wan L, Molloy SS, Thomas L, Liu G, Xiang Y, Rybak SL, Thomas G (1998) PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization. Cell 94:205–216. doi:10.1016/S0092-8674(00)81420-8 PubMedCrossRef Wan L, Molloy SS, Thomas L, Liu G, Xiang Y, Rybak SL, Thomas G (1998) PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization. Cell 94:205–216. doi:10.​1016/​S0092-8674(00)81420-8 PubMedCrossRef

go back to reference Rizzo WB (2007) Sjögren–Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol Genet Metab 90:1–9. doi:10.1016/j.ymgme.2006.08.006 PubMedCrossRef Rizzo WB (2007) Sjögren–Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol Genet Metab 90:1–9. doi:10.​1016/​j.​ymgme.​2006.​08.​006 PubMedCrossRef

go back to reference Rizzo WB, Carney G (2005) Sjögren–Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat 26:1–10. doi:10.1002/humu.20181 PubMedCrossRef Rizzo WB, Carney G (2005) Sjögren–Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat 26:1–10. doi:10.​1002/​humu.​20181 PubMedCrossRef

go back to reference Valle D, Goodman SI, Applegarth DA, Shih VE, Phang JM (1976) Type II hyperprolinemia: 1-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes. J Clin Invest 58:598–603. doi:10.1172/JCI108506 PubMedCrossRef Valle D, Goodman SI, Applegarth DA, Shih VE, Phang JM (1976) Type II hyperprolinemia: ¹-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes. J Clin Invest 58:598–603. doi:10.​1172/​JCI108506 PubMedCrossRef

go back to reference Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C (1998) 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 29:14–22. doi:10.1055/s-2007-973527 PubMedCrossRef Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C (1998) 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 29:14–22. doi:10.​1055/​s-2007-973527 PubMedCrossRef

go back to reference Vasiliou V, Pappa A (2000) Polymorphisms of human aldehyde dehydrogenases: consequences for drug metabolism and disease. Pharmacology 61:192–198. doi:10.1159/000028400 PubMedCrossRef Vasiliou V, Pappa A (2000) Polymorphisms of human aldehyde dehydrogenases: consequences for drug metabolism and disease. Pharmacology 61:192–198. doi:10.​1159/​000028400 PubMedCrossRef

go back to reference Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner M, Willemsen MAAP, Omran H, Tacke U, Uhlenberg B, Weschke B, Clayton PT (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12:307–309. doi:10.1038/nm1366 PubMedCrossRef Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner M, Willemsen MAAP, Omran H, Tacke U, Uhlenberg B, Weschke B, Clayton PT (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12:307–309. doi:10.​1038/​nm1366 PubMedCrossRef

go back to reference Deak KL, Dickerson ME, Linney E, Enterline DS, George TM, Melvin EC, Graham FL, Siegel DG, Hammock P, Mehltretter L, Bassuk AG, Kessler JA, Gilbert JR, Speer MC, NTD Collaborative Group (2005) Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2. Birth Defects Res A Clin Mol Teratol 73:868–875. doi:10.1002/bdra.20183 PubMedCrossRef Deak KL, Dickerson ME, Linney E, Enterline DS, George TM, Melvin EC, Graham FL, Siegel DG, Hammock P, Mehltretter L, Bassuk AG, Kessler JA, Gilbert JR, Speer MC, NTD Collaborative Group (2005) Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2. Birth Defects Res A Clin Mol Teratol 73:868–875. doi:10.​1002/​bdra.​20183 PubMedCrossRef

go back to reference Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H, Ueki A, Kitamura S, Namekata K, Miki T, Ohta S (2000) Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem Biophys Res Commun 273:192–196. doi:10.1006/bbrc.2000.2923 PubMedCrossRef Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H, Ueki A, Kitamura S, Namekata K, Miki T, Ohta S (2000) Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem Biophys Res Commun 273:192–196. doi:10.​1006/​bbrc.​2000.​2923 PubMedCrossRef

go back to reference Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, Wilkinson PA, Madrid RE, Patel H, Hentati F, Patton MA, Hentati A, Lamont PJ, Siddique T, Crosby AH (2008) Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 82:510–515. doi:10.1016/j.ajhg.2007.10.001 PubMedCrossRef Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, Wilkinson PA, Madrid RE, Patel H, Hentati F, Patton MA, Hentati A, Lamont PJ, Siddique T, Crosby AH (2008) Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 82:510–515. doi:10.​1016/​j.​ajhg.​2007.​10.​001 PubMedCrossRef